Abstract
The in vitrodissolution rates of prednisolone from five commercially available 5- mg prednisolone tablets were determined in distilled water. The dissolution studies were repeated on the fastest- and slowest-dissolving brands using 0.01% polysorbate 80 in 0.1 NHCl as the dissolution medium. A two-way crossover bioavailability study was performed in 12 human male adult volunteers comparing the fastest- and slowest-dissolving brands. The plasma samples were assayed for prednisolone by a radioimmunoassay method. Statistical analysis of the data for the two brands showed no significant differences between average plasma levels of prednisolone at any sampling time. The results suggest that on the average the in vivorates of dissolution of the two brands were essentially the same, and in vitrodissolution in 0.01% polysorbate 80–0.1 NHCl medium was better correlated with these in vivoresults than dissolution in water.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
An annotated list of drugs with a potential for therapeutic inequivalence based on current evidence of drug product bioavailability inequivalence.J. Am. Pharm. Ass. NS13: 279–280 (1973).
J. P. Isbister, J. Speras, and A. W. Steinbeck. The absorption of prednisolone B.P. 5 mg. and 25 mg. tablets.Med. J. Aust. 1: 1135–1136 (1969).
P. F. D'Arcy, J. P. Griffin, J. S. Jenkins, W. F. Kirk, and A. W. C. Peacock. Sustained-release formulation of prednisolone administered orally to man.J. Pharm. Sci. 60: 1028–1033 (1971).
J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971, p. 112.
P. Finholt and S. Solvang. Dissolution kinetics of drugs in human gastric juice-the role of surface tension.J. Pharm. Sci. 57: 1322–1326 (1968).
W. A. Colburn and R. H. Buller. Radioimmunoassay for prednisolone.Steroids 21: 833–846 (1973).
Information Bulletin, Tritiated-Digoxin Radioimmunoassay Kit, Schwarz/Mann, Orangeburg, N.Y.
Guidelines for Biopharmaceutical Studies in Man, APhA Academy of Pharmaceutical Sciences, Washington, D.C., 1972, p. 2.
Author information
Authors and Affiliations
Additional information
Supported by Contract CPF69-22, Food and Drug Administration, Washington, D.C., and in part by Public Health Service Grant 5-P11-GM15559.
An erratum to this article is available at http://dx.doi.org/10.1007/BF01071313.
Rights and permissions
About this article
Cite this article
Sullivan, T.J., Stoll, R.G., Sakmar, E. et al. In Vitro andIn Vivo availability of some commercial prednisolone tablets. Journal of Pharmacokinetics and Biopharmaceutics 2, 29–41 (1974). https://doi.org/10.1007/BF01062144
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062144